Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

被引：16
|
作者：
Rollig, Christoph
Kramer, Michael
Schliemann, Christoph
Mikesch, Jan-Henrik
Steffen, Bjorn
Kramer, Alwin
Sauer, Tim
Hanel, Mathias
Herbst, Regina
Schafer-Eckart, Kerstin
Noppeney, Richard
Jost, Edgar
Brummendorf, Tim H.
Krause, Stefan W.
Kunzmann, Volker
Einsele, Hermann
Scholl, Sebastian
Hochhaus, Andreas
Fransecky, Lars R.
Kaufmann, Martin
Neubauer, Andreas
Niemann, Dirk
Schaich, Markus
Frickhofen, Norbert
Kiani, Alexander
Heits, Frank
Krumpelmann, Ulrich
Kaiser, Ulrich
Kullmer, Johannes
Wass, Maxi
Klein, Stefan
Von Bonin, Malte
Middeke, Jan Moritz
Thiede, Christian
Stoelzel, Friedrich
Schetelig, Johannes
Ehninger, Gerhard
Baldus, Claudia D.
Muller-Tidow, Carsten
Platzbecker, Uwe
Serve, Hubert
Bornhauser, Martin
机构：
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-123717
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
13
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
    Roellig, Christoph
    Kramer, Michael
    Schliemann, Christoph
    Mikesch, Jan-Henrik
    Steffen, Bjoern
    Kramer, Alwin
    Noppeney, Richard
    Schaefer-Eckart, Kerstin
    Krause, Stefan W.
    Haenel, Mathias
    Herbst, Regina
    Kunzmann, Volker
    Einsele, Hermann
    Jost, Edgar
    Bruemmendorf, Tim H.
    Scholl, Sebastian
    Hochhaus, Andreas
    Neubauer, Andreas
    Sohlbach, Kristina
    Fransecky, Lars
    Kaufmann, Martin
    Niemann, Dirk
    Schaich, Markus
    Frickhofen, Norbert
    Kiani, Alexander
    Heits, Frank
    Kruempelmann, Ulrich
    Kaiser, Ulrich
    Kullmer, Johannes
    Wass, Maxi
    Stoelzel, Friedrich
    von Bonin, Malte
    Middeke, Jan Moritz
    Thiede, Christian
    Schetelig, Johannes
    Berdel, Wolfgang E.
    Ehninger, Gerhard
    Baldus, Claudia D.
    Muller-Tidow, Carsten
    Platzbecker, Uwe
    Serve, Hubert
    Bornhaeuser, Martin
    BLOOD, 2020, 136 (07) : 823 - 830
  • [2] Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens
    Baden, David
    Zukunft, Sven
    Hernandez, Gema
    Wolgast, Nadine
    Steinhaeuser, Sophie
    Pohlmann, Alexander
    Schliemann, Christoph
    Mikesch, Jan-Henrik
    Steffen, Bjoern
    Sauer, Tim
    Hanoun, Maher
    Schaefer-Eckart, Kerstin
    Krause, Stefan W.
    Haenel, Mathias
    Einsele, Hermann
    Jost, Edgar
    Bruemmendorf, Tim H.
    Scholl, Sebastian
    Hochhaus, Andreas
    Neubauer, Andreas
    Burchert, Andreas
    Kaufmann, Martin
    Niemann, Dirk
    Schaich, Markus
    Blau, Wolfgang
    Kiani, Alexander
    Goerner, Martin
    Kaiser, Ulrich
    Kullmer, Johannes
    Weber, Thomas
    Berdel, Wolfgang E.
    Ehninger, Gerhard
    Mueller-Tidow, Carsten
    Platzbecker, Uwe
    Serve, Hubert
    Bornhaeuser, Martin
    Roellig, Christoph
    Baldus, Claudia D.
    Fransecky, Lars
    HAEMATOLOGICA, 2024, 109 (08) : 2469 - 2477
  • [3] Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia
    Reville, Patrick K.
    Kadia, Tapan
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (04)
  • [4] Individualizing Treatment for Newly Diagnosed Acute Myeloid Leukemia
    Patrick K. Reville
    Tapan Kadia
    Current Treatment Options in Oncology, 2020, 21
  • [5] Leukapheresis in patients newly diagnosed with acute myeloid leukemia
    Villgran, Vipin
    Agha, Mounzer
    Raptis, Anastasios
    Hou, Jing-Zhou
    Farah, Rafic
    Lim, Seah H.
    Redner, Robert L.
    Im, Annie
    Sehgal, Alison
    Dorritie, Kathleen A.
    Kiss, Joseph E.
    Normolle, Daniel
    Boyiadzis, Michael
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 55 (02) : 216 - 220
  • [6] PROGNOSTIC FACTORS AND TREATMENT OUTCOME OF CHILDREN WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA.
    Zahra, K.
    Ben Sayed, N.
    Ben Youssef, Y.
    Zaier, M.
    Achour, B.
    Rgaieg, H.
    Khelif, A.
    HAEMATOLOGICA, 2014, 99 : 571 - 571
  • [7] An evaluation of no-treatment decisions in patients with newly diagnosed acute myeloid leukemia
    Brandwein, Joseph M.
    Hallett, Darren
    Karkhaneh, Mohammad
    Zhu, Nancy
    Liew, Elena
    Bolster, Lauren
    Hamilton, Marlene
    Patterson, Jeffrey
    Taparia, Minakshi
    Wu, Cynthia
    Van Slyke, Tiffany
    Bankar, Aniket
    Saini, Lalit
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (01) : E17 - E20
  • [8] Opioid utilization among pediatric patients treated for newly diagnosed acute myeloid leukemia
    Getz, Kelly D.
    Miller, Tamara P.
    Seif, Alix E.
    Li, Yimei
    Huang, Yuan-Shung V.
    Fisher, Brian T.
    Aplenc, Richard
    PLOS ONE, 2018, 13 (02):
  • [9] Low 25(OH) Vitamin D3 Levels Are Associated With Adverse Outcome in Newly Diagnosed, Intensively Treated Adult Acute Myeloid Leukemia
    Lee, Hun Ju
    Muindi, Josephia R.
    Tan, Wei
    Hu, Qiang
    Wang, Dan
    Liu, Song
    Wilding, Gregory E.
    Ford, Laurie A.
    Sait, Sheila N. J.
    Block, Annemarie W.
    Adjei, Araba A.
    Barcos, Maurice
    Griffiths, Elizabeth A.
    Thompson, James E.
    Wang, Eunice S.
    Johnson, Candace S.
    Trump, Donald L.
    Wetzler, Meir
    CANCER, 2014, 120 (04) : 521 - 529
  • [10] Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia
    Bertoli, Sarah
    Berard, Emilie
    Huguet, Francoise
    Huynh, Anne
    Tavitian, Suzanne
    Vergez, Francois
    Dobbelstein, Sophie
    Dastugue, Nicole
    Mansat-De Mas, Veronique
    Delabesse, Eric
    Duchayne, Eliane
    Demur, Cecile
    Sarry, Audrey
    Lauwers-Cances, Valerie
    Laurent, Guy
    Attal, Michel
    Recher, Christian
    BLOOD, 2013, 121 (14) : 2618 - 2626
12345